Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?

Table 1 Patients characteristics

Variable	Control group (n = 114)		Clopidogrel group (n = 126)		P-value
Patients characteristics
Sex, male	86	(75.4)	114	(86.5)	.028^a
Age	63	(57–70)	58	(52–65)	.001^b
Body weight	77.5	(68–84)	79	(69–85)	.874^b
Dyslipidemic	45	(39.5)	33	(26. 6)	.028^a
Smoker	85	(74. 6)	86	(68.3)	.281^a
Diabetic	67	(58.8)	50	(39.7)	.003^a
Hypertensive	73	(64.0)	72	(57. 6)	.276^a
Renal dysfunction	13	(11.4)	3	(2.4)	.005^a
Ejection Fraction	59	(50–63)	55.5	(45–63)	.368^b

ISSN: 1749-8090